Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
- PMID: 36037550
- PMCID: PMC9367206
- DOI: 10.1016/j.thromres.2022.08.005
Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
Keywords: Anti-PF4 antibodies; COVID-19 vector vaccine ChAdOx1; Spike subunit 1-specific antibodies.
Conflict of interest statement
Declaration of competing interest AW: support for attending ECCMID 2022 conference (Astra Zeneca); EGS: none, MK: investigator initiated research contract (Pfizer), consulting fees (Valneva, Bluesky vaccines Escientia), payment for lectures/presentations (Bristol – Myers Squibb), payment for expert testimony (Lundy, Lundy, Soileau & South, LLP); HS: none; IP: none; SE: none; PQ: none; OW: none; UW: none; KGP: none.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
